True TL - but for those astute investors (such as yourself and I...

True TL - but for those astute investors (such as yourself and I ;) ) we can see a picture developing.

The top half highlights the strategy that was implemented and that was to leverage TPM to generate income. Very few biotech's have that capacity and whilst we, like others, wait patiently for major pipeline development, we also generate income.
The bottom half highlights what goodies await those who wait. In other 6-12 months what products might sneak onto the existing revenue stream and what surprises will sneak onto the extended pipeline list.

I suspect as we get further industry validation we will see those other dormant products like psoriasis, dermatitis, haircare and maybe even foods all start coming to the forefront.

I believe we are entering a very important validation phase with external products such Diclofenac and mastitis research opening up a Pandora's box of opportunity.